ADP-ribosylation factor 4 pseudogene 4 (ARF4P4)

ARF4P4 (ARF GTPase 4 pseudogene 4) is a **pseudogene**, meaning it is a segment of DNA sharing sequence similarity with the functional ARF4 gene but lacking the ability to encode a functional protein due to disabling mutations or lack of proper regulatory elements[2][4]. Pseudogenes such as ARF4P4 typically do not produce functional products and are not currently considered therapeutic or pharmacological targets. Pseudogenes may sometimes have regulatory roles at the RNA level, such as acting as miRNA decoys or competing for regulatory factors, but no specific biological, disease, or drug interaction role is documented for ARF4P4[2][4].\nThe parent gene ARF4 encodes a class II ARF family GTPase involved in vesicular trafficking and phospholipase D activation, but the pseudogene does not possess these functions[1][3][4].\nNo chemical, pharmacological, or biomarker roles are known for ARF4P4.\n\nKey note:\nThis is not a functional therapeutic target, nor a receptor, enzyme, or transporter, and is thus not generally included in pharmacological or clinical target databases. If a functional ARF4 or other ARF family members are of interest, those would be valid targets, but not the pseudogene ARF4P4[1][3][4].

Other names

ARF4P4ARF GTPase 4 pseudogene 4ADP-ribosylation factor 4 pseudogene 4